A guide to fragment-based drug discovery
The Scientist
Most Recent
Researchers show that a synthetic peptide derived from a sea anemone toxin has potent weight-regulating effects in a mouse model of obesity.
The essential nutrient can kill drug-resistant Mycobacterium tuberculosis by producing oxidative radicals that damage DNA.
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
A researcher working for a US pharmaceutical company’s Scotland branch is sent to prison for falsifying safety test data on experimental drugs due for clinical trials.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
After a family friend died of pancreatic cancer, high school sophomore Jack Andraka invented a diagnostic strip that could detect the disease in its early stages.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
